FAKTOR OPTIONSSCHEIN - AMGEN | Real-time BOERSE MUENCHEN 11:15:50 13/05/2024 pm IST | ||
| 7 EUR | +3.40% |
|
| Current month | -38.90% | ||
| 1 month | -44.10% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/24/13 | 7 | +3.40% | 0 |
| 10/24/10 | 6.77 | +2.27% | 0 |
| 09/24/09 | 6.62 | -7.80% | 0 |
| 08/24/08 | 7.18 | -5.65% | 0 |
| 07/24/07 | 7.61 | -0.13% | 0 |
Real-time BOERSE MUENCHEN
Last update May 13, 2024 at 11:15 pm IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD2VEF |
| ISIN | DE000HD2VEF0 |
| Date issued | 21/02/2024 |
| Strike | 413.6 $ |
| Maturity | Unlimited |
| Parity | 14.48 : 1 |
| Emission price | 10.24 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 12.86 € |
|---|---|
| Lowest since issue | 6.13 € |
| Spread | 0.01 € |
| Spread % | 0.14% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
310.2
USD
Average target price
314.6
USD
Spread / Average Target
+1.45%
- Stock Market
- Certificates
- Certificat
